Submitted by Anonymous (not verified) on 2 March 2026 - 15:45
Human medicines European public assessment report (EPAR): Pylclari, piflufolastat (18F), Date of authorisation: 27/11/2023, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Pylclari, piflufolastat (18F), Date of authorisation: 27/11/2023, Revision: 8, Status: Authorised